TCM
CERE
Tekla Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $5.61M | Hold |
176,483
| – | – | 0.22% | 83 |
|
|
2023
Q1 | $4.3M | Hold |
176,483
| – | – | 0.16% | 84 |
|
|
2022
Q4 | $5.57M | Hold |
176,483
| – | – | 0.21% | 75 |
|
|
2022
Q3 | $4.99M | Buy |
176,483
+88,310
| +100% | +$2.5M | 0.2% | 79 |
|
|
2022
Q2 | $2.33M | Buy |
88,173
+14,492
| +20% | +$383K | 0.09% | 108 |
|
|
2022
Q1 | $2.58M | Buy |
73,681
+32,678
| +80% | +$1.14M | 0.09% | 117 |
|
|
2021
Q4 | $1.33M | Buy |
+41,003
| New | +$1.33M | 0.04% | 141 |
|